id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0719-0010,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-05-21T04:00:00Z,2020,5,2020-05-21T04:00:00Z,,2020-05-21T13:03:58Z,2020-10977,0,0,090000648465d77c
FDA-2013-N-0719-0009,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Planning for the
Effects of High Absenteeism To Ensure Availability of Medically
Necessary Drug Products",Notice,30 Day Proposed Information Collection,2020-02-03T05:00:00Z,2020,2,2020-02-03T05:00:00Z,2020-03-05T04:59:59Z,2020-02-03T15:14:10Z,2020-01992,0,0,0900006484320785